欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/1091/002
药品名称Meropenem 1 g powder for solution for injection or infusion
活性成分
    • meropenem trihydrate 1000.0 mg
剂型Powder for solution for infusion/injection
上市许可持有人Acino AG, (2168), (LOC-100038152), Leopoldstrasse 115, Schwabing-Freimann, Munich, Bavaria, 80804, Germany
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Merothen
    • Poland (PL)
      Meropental
    • Greece (GR)
      PENEMNIA
    • Cyprus (CY)
许可日期2011/11/10
最近更新日期2024/03/14
药物ATC编码
    • J01DH02 meropenem
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase